» Articles » PMID: 17623264

Towards the Molecular Characterization of Disease: Comparison of Molecular and Histological Analysis of Esophageal Epithelia

Overview
Specialty Gastroenterology
Date 2007 Jul 12
PMID 17623264
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Reliable quantification of gene expression offers the possibility of more accurate and prognostically relevant characterization of tissues than potentially subjective interpretations of histopathologists. We measured the expression of 18 selected genes and compared them to histological features in a spectrum of esophageal disease to evaluate the feasibility of molecular characterization of normal and pathologic esophageal epithelia. Esophageal tissue biopsies from 82 patients with foregut symptoms were laser capture microdissected, and the expression levels of 18 selected genes were measured by quantitative real-time polymerase chain reaction. Linear discriminant analysis, which uses combinations of genes to distinguish between histological groups, was performed to compare gene expression and the following five histological groups: (1) normal squamous epithelium (n = 35), (2) reflux esophagitis (n = 13), (3) non-dysplastic Barrett's (n = 33), (4) dysplastic Barrett's (n = 16), (5) adenocarcinoma (n = 31). A panel of seven genes had 90-94% predictive power to distinguish non-dysplastic and dysplastic Barrett's esophagus. Clustering analysis revealed structure in gene expression values even in the absence of histology. Expression levels in 17 genes differed significantly across histological groups. Classification based on gene expression agreed with histopathological assessment in the following percentage of cases: normal squamous epithelium = 53%, reflux esophagitis = 31%, non-dysplastic Barrett's = 76%, dysplastic Barrett's = 40%, and adenocarcinoma = 59%. Interestingly, predictive power improved markedly when inflammatory and dysplastic tissues were removed (77-94%). Gene expression classification agrees well with histopathological examination. When differences occur, it is unclear whether this effect is due to intraobserver variability in pathological diagnosis or to a genuine difference between gene expression and histopathology.

Citing Articles

Accuracy of identification of tissue types in endoscopic esophageal mucosal biopsies used for molecular biology studies.

Beck P, Mayne G, Astill D, Irvine T, Watson D, Dijckmeester W Clin Exp Gastroenterol. 2011; 2:1-7.

PMID: 21694820 PMC: 3108633.


The columnar-lined mucosa at the gastroesophageal junction in non-human primates.

Rubio C, Dick E, Schlabritz-Loutsevitch N, Orrego A, Hubbard G Int J Clin Exp Pathol. 2009; 2(5):481-8.

PMID: 19294007 PMC: 2655154.

References
1.
Kuramochi H, Vallbohmer D, Uchida K, Schneider S, Hamoui N, Shimizu D . Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma. J Gastrointest Surg. 2004; 8(8):1007-16. DOI: 10.1016/j.gassur.2004.09.025. View

2.
Vallbohmer D, Demeester S, Peters J, Oh D, Kuramochi H, Shimizu D . Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus. Dis Esophagus. 2006; 19(4):260-6. DOI: 10.1111/j.1442-2050.2006.00586.x. View

3.
Vallbohmer D, Peters J, Oh D, Kuramochi H, Shimizu D, DeMeester S . Survivin, a potential biomarker in the development of Barrett's adenocarcinoma. Surgery. 2005; 138(4):701-6. DOI: 10.1016/j.surg.2005.06.051. View

4.
Khan J, Saal L, Bittner M, Chen Y, Trent J, Meltzer P . Expression profiling in cancer using cDNA microarrays. Electrophoresis. 1999; 20(2):223-9. DOI: 10.1002/(SICI)1522-2683(19990201)20:2<223::AID-ELPS223>3.0.CO;2-A. View

5.
Lenz H, Danenberg K, Leichman C, Florentine B, Johnston P, Groshen S . p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. Clin Cancer Res. 1998; 4(5):1227-34. View